Castration is a prerequisite for the inhibitory effect of metronomic chemotherapy on the growth of experimental castration-resistant prostate cancer by Jellvert, Åsa, Åhs, Daniel, Olausson, Josefin, Franck Lissbrant, Ingela, Damber, Jan-Erik, Welén, Karin

Get full text

Effect of docetaxel added to bicalutamide in Hormone-Naïve non-metastatic prostate cancer with rising PSA, a randomized clinical trial (SPCG-14) by Josefsson, Andreas, Jellvert, Åsa, Holmberg, Erik, Brasso, Klaus, Meidahl Petersen, Peter, Aaltomaa, Sirpa, Luukkaa, Marjaana, Verhagen, Paul, de Wit, Ronald, Ahlgren, Göran, Andrén, Ove, Castellanos, Enrique, Seke, Mihalj, Widmark, Anders, Damber, Jan-Erik

Get full text

Niraparib in patients with metastatic castration-resistant prostate cancer and DNA repair gene defects (GALAHAD): a multicentre, open-label, phase 2 trial by Smith, Matthew R, Scher, Howard I, Sandhu, Shahneen, Efstathiou, Eleni, Lara, Primo N, Yu, Evan Y, Chi, Kim N, Ståhl, Olof, Olmos, David, Danila, Daniel C, Espina, Byron M, Zhao, Xin, Urtishak, Karen A, Francis, Peter, Lopez-Gitlitz, Angela, Parnis, Francis, Horvath, Lisa G., Steer, Christopher, Marx, Gavin, Sandhu, Shahneen, Ferguson, Thomas, Luyten, Daisy, Lumen, Nicolaas, Dirix, Luc, Goeminne, Jean-Charles, Gil, Thierry, Vulsteke, Christof, Kussumoto, Celio, Franke, Fabio A., Martinelli de Oliveira, Fabricio Augusto, Pereira de Santana Gomes, Andrea Juliana, Preto, Daniel D'Almeida, Zucca, Luis Eduardo, Borges, Giuliano Santos, Murad, Andre M., Saad, Fred, Chi, Kim N., Fradet, Yves, Fleshner, Neil E., Emmenegger, Urban, Brasso, Klaus, Culine, Stephane, Thiery-Vuillemin, Antoine, Joly, Florence, Fléchon, Aude, Hilgers, Werner, Borchiellini, Delphine, Barthélémy, Philippe, Berger, Raanan, Mermershtain, Wilmosh, Peer, Avivit, Sella, Avishay, Voortman, Johannes, Aarts, Maureen J., Gietema, Jourik A., Choi, Young-Deuk, Gafanov, Rustem A., Kopyltsov, Evgeniy, Carles, Joan, Mellado, Begoña, Maroto, José Pablo, García-Donás, Jesús, Rodríguez Moreno, Juan Francisco, Durán, Ignacio, Pérez-Valderrama, Begoña, Castro, Elena, Olmos, David, Méndez-Vidal, María José, Muñoz-Langa, José, Herranz, Urbano Anido, Puente Vázquez, Javier, Castellanos, Enrique, Hellström, Martin, Widmark, Anders, Lissbrant, Ingela Franck, Jellvert, Åsa, Külich, Cecilia, Blom, René, Kang, Chih-Hsiung, Ou, Yen-Chuan, Wang, Shian-Shiang, Attard, Gerhardt, Bahl, Amit, Kellati, Prasad, Parikh, Omi, Srinivasan, Rajaguru, Lester, Jason F., Staffurth, John N., Cheng, Heather H., Efstathiou, Eleni, Pilié, Patrick G., George, Daniel J., Karsh, Lawrence I., Kelly, W. Kevin, Danila, Daniel C., Smith, Matthew R., Heath, Elisabeth I., Vaishampayan, Ulka N., Emamekhoo, Hamid, Pinski, Jacek K.

Get full text

Effective oral combination metronomic chemotherapy with low toxicity for the management of castration-resistant prostate cancer by JELLVERT, ÅSA, LISSBRANT, INGELA FRANCK, EDGREN, MALIHA, ÖVFERHOLM, ELISABETH, BRAIDE, KARIN, OLVENMARK, ANN-MARIE EKELUND, KINDBLOM, JON, ALBERTSSON, PER, LENNERNÄS, BO

Get full text

Ilixadencel, a Cell-based Immune Primer, plus Sunitinib Versus Sunitinib Alone in Metastatic Renal Cell Carcinoma: A Randomized Phase 2 Study by Lindskog, Magnus, Laurell, Anna, Kjellman, Anders, Melichar, Bohuslav, Rey, Pablo Maroto, Zieliński, Henryk, Villacampa, Felipe, Bigot, Pierre, Zoltan, Bajory, Parikh, Omi, Alba, David Vazquez, Jellvert, Åsa, Flaskó, Tibor, Gallardo, Enrique, Caparrós, Maria José Ribal, Purkalne, Gunta, Suenaert, Peter, Karlsson-Parra, Alex, Ljungberg, Börje

Get full text